IPA NASDAQ

ImmunoPrecise Antibodies Ltd. - Common Stock

Healthcare · Life Sciences Tools & Services
7
Quality Score
fail
Mkt Cap
$126.9M
ROE
-148.1%
Margin
-192.2%
D/E
51.46
Beta
0.72
52W
$0–$3

Fundamentals Trend

Metric 2024-04-30 2024-07-31 2024-10-31 2025-01-31 2025-04-30 2025-09-02
ROE (TTM) -57.3% -65.5% -73.8% -148.1% -105.8% -148.1%
P/E (TTM)
Net Margin -279.4% -76.0% -41.7% -349.9% -31.0% -192.2%
Gross Margin 48.1% 44.8% 56.1% 53.6% 63.9% 50.8%
D/E Ratio 40.33 49.00 50.26 51.46 56.73 51.46
Current Ratio 1.41 0.99 1.01 2.32 2.08 2.32

Key Ratios

ROA (TTM)
-82.1%
P/S (TTM)
7.34
P/B
1.4
EPS (TTM)
$-1.57
Rev Growth 3Y
+11.0%
52W High
$3.25
52W Low
$0.27

How does IPA compare to Life Sciences Tools & Services peers?

Peer group: Micro-cap Life Sciences Tools & Services (All) · 44 companies

IPA valuation vs Life Sciences Tools & Services peers

P/E ratio
0% below peers (32.5)
vs Peers
vs Industry
Undervalued
P/S ratio
7.3
96% above peers (3.7)
vs Peers
vs Industry
Overvalued
P/B ratio
1.4
30% below peers (2.0)
vs Peers
vs Industry
Undervalued
Div yield
0% below peers (0.5%)
vs Peers
vs Industry
Low yield

IPA profitability vs Life Sciences Tools & Services peers

ROE
-148.1%
500% below peers (-24.7%)
vs Peers
vs Industry
Weak
Net margin
-192.2%
591% below peers (-27.8%)
vs Peers
vs Industry
Weak
Gross margin
50.8%
5% above peers (48.2%)
vs Peers
vs Industry
In line
ROA
-82.1%
464% below peers (-14.6%)
vs Peers
vs Industry
Weak

IPA financial health vs Life Sciences Tools & Services peers

D/E ratio
51.5
122% above peers (23.2)
vs Peers
vs Industry
High debt
Current ratio
2.3
30% below peers (3.3)
vs Peers
vs Industry
Low liquidity
Beta
0.7
48% below peers (1.4)
vs Peers
vs Industry
More volatile

IPA fundamentals radar

IPA Peer median Industry

IPA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

IPA vs peers: key metrics